SCHEMBL7243144

SCHEMBL7243144

CCC(=O)COCCOCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.46
THRB P10828 1/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
ALDH1A1 P00352 3/20 0.44
TDP1 Q9NUW8 1/20 0.39
CES2 O00748 2/20 0.33
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
CASP1 P29466 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLCO1B3 Q9NPD5 1/20 0.31
SLCO1B1 Q9Y6L6 1/20 0.31
EPHX2 P34913 1/20 0.31
ACHE P22303 1/20 0.31
CYP4F2 P78329 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15223141 0.95
SCHEMBL19170656 0.84 TDP1 (0.41) MEN1KMT2ATSHRTHRBHTT
SCHEMBL29997828 0.83 MEN1 (0.47) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL20317554 0.82 TDP1 (0.39) TSHRALDH1A1TDP1CES2CYP3A4
SCHEMBL14403358 0.82 TDP1 (0.39) TSHRALDH1A1TDP1CES2CYP3A4
SCHEMBL22856291 0.82 CES2 (0.52) TSHRTHRBALDH1A1TDP1CES2
SCHEMBL8390457 0.82 TDP1 (0.39) TSHRALDH1A1TDP1CES2CYP3A4
SCHEMBL10072103 0.81 MEN1 (0.55) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL25290891 0.80 CES2 (0.45) MEN1KMT2ATSHRTHRBHTT
SCHEMBL16421150 0.80 TDP1 (0.38) TSHRALDH1A1TDP1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620771-B2 Extreme pressure additives for lubricating compositions (e.g., greases) R. T. VANDERBILT COMPANY, INC. 2003-09-16 US disclosed
US-20020058594-A1 Thiadiazole dimer additives and lubricating compositions containing the same R.T. VANDERBILT COMPANY, INC. (US) 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058594-A1 Thiadiazole dimer additives and lubricating compositions containing the same RAD51, TPR, LIG1 MEN1 4395/4885KMT2A 3668/4885TSHR 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.